Effect of Transcranial Static Magnetic Field Stimulation in Fibromyalgia Syndrome

Effect of Transcranial Static Magnetic Field Stimulation Over the Primary Motor Cortex in Fibromyalgia Syndrome: A Randomized Controlled Pilot Study

The main objective is to know if the transcranial static magnetic field stimulation (tSMS) reduces the perception of pain in patients with fibromyalgia and its effect on health-related quality of life. In addition, it will seek to limit the parameters necessary to achieve efficiency with the technique.

Background:

Various non-invasive brain stimulation techniques have been successfully tested in fibromyalgia syndrome (FMS). Transcranial static magnetic field stimulation (tSMS) is a new, portable and inexpensive non invasive brain stimulation (NIBS) technique that has shown security, biological effects, and therapeutical effects in some pathologies. Some studies have studied its effect in pain central processing, our aim is to study its effect on FMS. The safety that tSMS has demonstrated in several clinical trials opens doors to future clinical trials that will extend its clinical utility.

Objectives:

To investigate the effect of tSMS on pain in patients with FMS, using subjective and objective assessment measures. Identify dose response to the treatment to limit the parameters required to achieve effectiveness with the technique.

Inclusion Criteria:

• Formal diagnosis of fibromyalgia syndrome (FMS).
• No change in the last 4 weeks on their standard treatment.
• They must have pain for more than 6 months (at least 4 on the VAS scale).
• Score on the fibromyalgia impact questionnaire (FIQ) greater than 39.

Exclusion Criteria:

• Presence of concomitant autoimmune or hematologic diseases.
• Neuropsychiatric disorders.
• Pacemakers or neurostimulators implants.
• Substance abuse or other pathologies that can explain chronic pain.
• Pregnant or lactating women.
• Those who are receiving any other type of physiotherapy treatment.